Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anesta/Abbott Actiq oral fentanyl may be used for chronic cancer and AIDS-related pain, FDA indicates.

Executive Summary

ANESTA/ABBOTT ACTIQ MAY BE USED FOR BOTH CANCER AND AIDS BREAKTHROUGH PAIN episodes even though Anesta's NDA for fentanyl on a handle was based solely on data from chronic cancer pain patients, FDA Division of Anesthetic, Critical Care & Addiction Drug Products Deputy Director Curtis Wright, MD, indicated at Actiq's Sept. 17 review by the Anesthetic and Life Support Drugs Advisory Committee. "We have not, as a division, differentiated between cancer pain and other severe chronic pain requiring opioid therapy, except as pertains to matters of safety," Wright said in response to committee members' inquiries about use in AIDS patients.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel